Taking advantage of our understanding of the peptide specifidty of the major histocompatibility complex class I-b molecule M3 ~, we sought to determine why these molecules are poorly represented on the cell surface. To this end we constructed a chimeric molecule with the ott and c~2 domains of M3 ~ and or3 of L a thereby allowing use of available monoclonal antibodies to quantify surface expression. Transfected, but not control, B10.CAS2 (H-2M3 b) cells were lysed readily by M3 '-restricted monoclonal cytotoxic T lymphocytes. Thus, the chimera bound, trafficked, and presented endogenous mitochondrial peptides. However, despite high levels of M3~-L a mRNA, transfectants were negative by surface staining. This finding was consistent with ineffident trafficking to the cell surface. Incubation at 26~ thought to permit trafficking of unoccupied heavy (H) chains, resulted in detectable cell surface expression of chimeric molecules. Incubation with exogenous peptide at 26~ (but not at 37~ greatly enhanced expression of M3'-L a molecules in a dose-dependent manner, suggesting stabilization of unoccupied molecules. Stable association of ~2-microglobulin with the chimeric H chain was observed in labeled cell lysates only in the presence of exogenous specific peptide, indicating that peptide is required for the formation of a ternary complex. These results indicate that surface expression of M3'-L a is limited largely by the steady-state availability of endogenous peptides. Since most known M3'-binding peptides are N-formylated, native M3' may normally be expressed at high levels only during infection by intracellular bacteria.
M
HC class I molecules monitor the interior of cells for the presence of peptides derived from pathogens such as viruses and intracellular bacteria (1, 2) . Proteins are thought to be degraded into peptides by proteasomes (3, 4) and delivered to the endoplasmic reticulum through the ATP-dependent transporter associated with antigen processing (TAP) 1 (5, 6) . In the endoplasmic reticulum, the nascent MHC-encoded transmembrane H chain (44,000 Mr) forms a ternary complex with fl2-microglobulin (flzm) (12,500 Mr) (7) and a peptide of 8-10 amino acids in length (8) . In the absence of infection, cellular proteins serve as peptide donors. Studies using a variety of mutant cell lines, such as the TAP-mutant RMA-S (9, 10) and the fl2m-deficient R1E (11, 12) , have clearly demonstrated the need for all three components of the MHC molecule to be in the endoplasmic reticulum for
We have chosen to hyphenate I-a and l-b to avoid confusion of l-a with Ia as an original designation for MHC class II molecules.
1Abbreviations used in this paper:/32m, ]32-microglobulin; GAM, goat antimouse; mCTL, monoclonal CTL; RT, reverse transcriptase; TAP, transporter associated with antigen processing.
proper cell surface expression. At the cell surface, the MHC class I molecule presents peptides to CD8 + T cells (13, 14) .
In the mouse, MHC class I H chain genes can be classified into the highly polymorphic, class I-a (classical) K, D, and L and the relatively invariant, class I-b (nonclassical) Q, T, and M (15) . Mounting evidence indicates that class I-b gene products can bind and present peptides to CD8 + T cells (16) (17) (18) (19) . Similar to other MHC class I molecules, M3' associates with/32m and peptide and can present peptides to T cells (20) (21) (22) (23) . The biochemical specificity of M3 a is striking in that it binds N-formylated peptides (24, 25) . Because bacteria and mitochondria both initiate protein synthesis with N-formyl methionine, we hypothesized that M3' binds N-formylated peptides of bacterial origin for presentation to T cells (26) . Consistent with this hypothesis, recent data have shown that M3 a presents peptides from Listeria monocytogenes (27, 28) .
To study the intracellular requirements for peptide binding and cell-surface expression of M3L we assessed synthetic levels of H chain. At the mRNA level, M3 a expression has been detected in a variety of cell types and tissues, and is especially high in the thymus (29) . However, an abundant level of class I mR.NA transcripts does not necessarily equate to abundant cell surface expression. For instance, Qa-1 b transcripts are present at levels comparable to those of H-2K and D genes, but the amount of surface product is quite low (30) . The same holds true for H-2L d (31, 32) . Moreover, the cell surface expression of L a can be induced by peptide, suggesting that some H chain is retained intracellularly (33) .
As in other systems, a specific antiserum or mAb is critical for tracking the H chain through the cell. To date, however, efforts by ourselves and others to generate a specific antiserum to M3 a have been unsuccessful. To circumvent this problem, we developed an MHC class I chimeric molecule in which the o~1 and o~2 domains are derived from M3 a and the o~3 domain from L a. Moreover, this construct is driven by the K b promoter, which has strong constitutive expression and is readily inducible by IFN-% Similar chimeric Kbm-L a molecules were recognized by Kb~-specific CTLs and found at abundant levels on the cell surface of transfected cells (34) . In contrast, we found that M3a-L a chimeras were not expressed at the cell surface constitutively in quantities adequate for serological detection. In these studies, we determined the intracellular requirements for expression of the M3~-L d chimera.
Materials and Methods
Construction of the MHC Class I Chimera Vector. The M3~-L d expression vector was derived from pKb-L d, a gift from Dr. Larry Pease (Mayo Clinic, Rochester, MN). The exons that encode al and c~2 domains of M3 a replaced the corresponding exons in the original vector utilizing restriction endonuclease sites that were introduced in the original vector. Exons 2 and 3 of M3 ' were generated independently by genomic PCR. Specifically, intronic oligonucleotides that flank each exon were used to amplify these gene segments from NZB/B1NJ genomic DNA. For exon 2, the 5' oligonucleotide (5'-CAATGCTTGTCGACTGGCCC) possessed a SalI site and the 3' oligonucleotide (5'-AGAGCTCTGAAGCCC-AACTCCAAACATCTAAGCTTGCACCCA) had a HindlII site. The gel-purified DNA was separated from the agarose using Magic PCR preps (Promega, Madison, WI). The DNA was cut with SalI and HindlII and cloned into pBluescript II SK-(Stratagene, La Jolla, CA). The resultant plasmid (termed pM3~-C~l) was transformed into XL-1 Blue Escherichia coli (Stratagene). Plasmid DNA was prepared using Magic Mini-prep (Promega) and sequenced using Sequenase Version 2.0 (US Biochemical, Cleveland, OH) to ensure that the clone was free of PCR-induced mutations. The sequenced insert was cut with SalI and HindlII and ligated into the similarly cut pKb-L a vector, creating pM3~,,1Kb,~2-Ld. The process was repeated to obtain exon 3 of M3 '. In this case the 5' (5'-GGA-GTTGGGCTTCAGAGCTCTCAGAAAGCTTTAACC) and the 3' oligonucleotides (5'-TTCCTCCCTCTCGAGACATCA) had a HindllI and XhoI site, respectively. The resultant plasmid (termed pM3'-az) was transformed into XL-1 Blue E. coli (Stratagene).
After sequencing, the pM3'-oe~ insert was cut with HindlII and XhoI and ligated into the pM3"~lKb~2-Ld vector cut with HindlII and XhoI, creating pM3'-L d.
Antibodies. Supernatants of hybridomas were used for im- Cytotoxic T Lymphocyte Generation. The fNDl~-specific, M3'-restricted monoclonal CTL (mCTL) clones 1D8 and 3D5 were described elsewhere (24) . These mCTLs are specific for a peptide from the mitochondrial gene product ND1 (NADH dehydrogenase subunit 1) in the context of M3 ~. OVA-specific polyclonal CTL were produced by immunizing C57BL/6J (B6) mice with 5 x 103 E.G7-OVA cells (EL4 cells transfected with chicken OVA gene [13] ). After 2-3 wk, spleen cells of immunized B6 mice were cultured for 3-6 d with E.G7-OVA (',/-irradiated 20,000 tad) and syngeneic cells (3/-irradiated 3,000 tad). OVA-specific CTL clone 2G12 was obtained by limiting dilution and was shown to be restricted by H-2K b (25) .
Peptide Synthesis and Purification. The f-ND1%12 peptide corresponds to the NH2-terminus of ND1. f-Bla-zl-8 peptide, from
Bacillus cereus ~-lactamase binds to M3 ~ as determined by CTL competition assays (26) . Ac-Bla-z and Bla-z are the N-acetylated and unsubstituted forms of this peptide, respectively, f-L25 is from E. coli ribosomal protein L25 and also can bind to M3L
VSVNPs2-59 is the vesicular stomatitis virus nucleocapsid peptide that binds to K b, but not to M3 ~ (25) . All peptides were synthesized and HPLC purified as described previously (38) .
Cell Culture. SVCAS2.F6 tail cell fibroblasts were generated from B10.CAS2 mice (H-2 w17, M3 b) using SV-40-mediated transformation. These cells were transfected with EcoRI linearized pM3~-L d and KpnI linearized ppo12 (vector encoding G418 resistance) (39) at a molar ratio of 20:1, by CaPO4 precipitation. Cells resistant to 1 mg/ml G418 were isolated by ring cloning and grown in separate wells. 35 cell lines were generated from two independent transfections. To generate subline 13S2, cell line "13" was incubated with 500 nM f-Bla-z peptide overnight at 26~ The ceUs were stained as described below, omitting the fixing step. Cells were selected using a cell sorter (EPICS model 753; Coulter Electronics, Hialeah, FL) for high expression of the 28-14-8S epitope, and returned to culture media. After 1 wk, this process was repeated to generate subline 13S2 (cell line 13 sorted twice, hence 13S2). Cells were then passaged in DMEM plus 10% FCS, 1% gentamicin reagent solution, 1 mg/ml total G418 at 37~ in 5% CO2. E.G7 cells were passaged using the same medium. 24SV cells were generated from (B10.CAS2 x NZB/B1NJ) F1 tail cell fibroblasts (40) using SV40-mediated transformation. 24SV and SVCAS2.F6 cells were passaged in DMEM plus 10% FCS (40) . All cell culture reagents were from Gibco BILL (Gaithersburg, MD). Immunofluorescence Staining and Flow Cytometry Analysis. Immunofluorescence analysis was done as described (40) . Briefly, subconfluent transfected cells were incubated with the designated peptide for 12-16 h at 37~ or 26~ in culture media. Cells were trypsinized, collected, and washed three times in ice-cold PBS before resuspension in PBS at a final concentration of 107 cells/ml. 100 #1 of cell suspension were incubated with 100 #1 of mAb in the appropriate dilution for 30 rain at 4~ After two washes with cold PBS, the cells were stained with a 1:50 dilution of FITCconjugated goat anti-mouse (GAMIg) antibodies (Baxter, Mundelein, IL) for 30 rain at 4~ Samples were then fixed with 1% paraformaldehyde (vol/vol in PBS) and analyzed on a flow cytometer (EPICS Profile, Coulter Electronics). Data are expressed as mean log fluorescence of a population on a four decade scale (0.1-1,000) Voltages were adjusted to ensure that control staining with the secondary antibody alone (FITC-GAMIg) was in the range of 1 + 0.2 U. Additionally, gates were set around narrow windows of forward light scatter to minimize cell size-dependent artifacts (40) . Iodination of cell surface molecules was catalyzed by lactoperoxidase (44) . Briefly, 3 x 107 cells cultured at either 37~ or 26~ for 12 h in the presence or absence of specific peptide were washed three times in ice-cold PBS and labeled with 180 #1 of 1 mg/ml lactoperoxidase, 125 #1 of 0.045% H~O2 in PBS, and 2.5 mCi lz5I (17-20 Ci/mM on analysis date; NEN Research Products) for 15 rain. The reaction was terminated by the addition of 10 ml of icecold PBS.
Preparation of Radiolabeled Proteins.

Immunoprecipitation and SDS-PAGE. For in vitro stabilization
of the MHC complex, lysates were centrifuged at 15,000 g for 15 rain at 4~ An aliquot of the supernatant was precipitated with TCA to assess total radiolabel incorporation. Aliquots of supernatants were equalized on the basis of total radioactivity and incubated with specific peptide at 4~ for 16 h. The lysates were precleared using 150 #1 of BSA-Sepharose, goat anti-mouse-Sepharose (GAMIg from Pel-Freez Biologicals, Rogers, AR), and protein A-Sepharose (Pierce, Rockford, IL) sequentially for 5 min each at room temperature. Precleared lysates were divided into three tubes and incubated with specific or control antibodies at 4~ overnight. The immune complexes were collected on protein-A-Sepharose at 4~ for 1 h and washed four times with 0.5% NP-40, 0.25% sodium deoxycholate, 0.1% SDS in Tris-buffered saline, and two times with water. Immunoprecipitates were eluted from protein A-Sepharose in SDSsolubilizing buffer (pH 6.8) containing 62.5 mM Tris, 10% (vol/vol) glycerol, 3% (wt/vol) SDS, and 5% (vol/vol) 2-ME, and analyzed by SDS-PAGE on a 12.5% gel as described by Laemmli (45) . SDS-PAGE low range molecular weight standards (Bio-Rad Laboratoties) were used. The gels were treated with Amplify (Amersham Corp., Arlington Heights, IL), dried, and fluorographed at -70~ Gels were also analyzed on a Betascope 603 Blot Analyzer (Betagen, Mountain View, CA). The specific activity of the H chain and/32m bands was determined by subtracting the mean background count from the actual values. For l~I-labeled proteins, the procedure was identical except that cell lysates were directly immunoprecipitated after precleating, and after samples were analyzed by SDS-PAGE, the gels were dried and autoradiographed at -70~
Immunoblots. Subconfluent 13S2 cells were harvested, washed, and lysed in lysis buffer. Lysates were electrophoresed through a 12% SDS-PAGE gel. For convenience, Rainbow TM protein molecular weight markers (Amersham Corp.) were used. This gel was electroblotted (Trans-Blot Cell; Bio-Rad Laboratories) to Hybond C (Amersham Corp.) at 30 V for 16 h in Towbin transfer buffer (46) . The blots were blocked with 5% (wt/vol) non-fat dry milk in PBS-T (PBS plus 0.05% Tween-20) for 1 h and washed three times with 1% non-fat dry milk in PBS-T. The blots were probed with 28-14-8S in 1% non-fat dry milk in PBS-T for 1 h at room temperature. After three extensive washes, GAMIgG conjugated to horseradish peroxidase (Amersham Corp.) was added at a dilution of 1:3,000 and incubated for 1 h. The blots were washed as before and developed using the enhanced chemiluminescent detection system (Amersham Corp.) and exposed to film. with little, if any, involvement of the cr region (47) . In particular, Allen et al. (48) showed that L cells expressing a K b (cr c~2)-L d (c~3) hybrid molecule were lysed by Kb-restricted CTLs equivalently to fibroblasts expressing the native K b molecule. A useful feature of the L d c~3 domain is that a mAb (28-14-8S) exists that binds to a conformationallyinsensitive epitope independently of the antigen-binding domain (35) . Concerns that the c~3 domain of the L a molecule might not bind/52m well (49) were alleviated by two studies demonstrating that the inability of native L a to associate stably with ~2m is determined by the c~l domain (50, 51) . Therefore, the L a o~3 domain itself possesses the capacity to bind functionally with B2m.
The M3a-L d Chimera Renders SVCAS2.F6 (M3 b) Fibroblasts Sensitive to Lysis by M3a-restricted mCTLs. The chimera was transfected along with a drug-selecting marker into SVCAS2.F6 fibroblasts derived from the H-2 w17 mouse strain B10.CAS2. This mouse strain carries a different allele of the H chain (M3b), rendering these fibroblasts resistant to lysis by M3~-restricted mCTLs (52) . To determine whether the chimera could bind the endogenous mitochondrial peptide ND1 ~ and traffic to the cell surface, G418-resistant fibroblasts were incubated with M3a-restricted, NDl~-specific mCTL (Fig. 2 a) . Transfected cells were lysed readily by the mCTL, whereas the untransfected control cells were not lysed. These data suggested that the MHC molecule appropriately bound, trafficked, and presented endogenous peptides. Moreover, this lysis was dose-dependent on mCTL (Fig. 2 b) . To demonstrate that DNA transfection did not cause these fibroblasts to be nonspecific targets of CTL-mediated lysis, transfectants were incubated with OVAspecific mCTLs that recognize the OVA peptide bound to K b (25) . As expected, OVA-specific mCTLs failed to lyse transfected targets (Fig. 2 b) . tants were tested in a cell-mediated cytolysis assay for their sensitivity to NDl'~-specific, M3~-restricted killing at an E/T ratio of 1:1 with clone 1D8. The cell line 24SV, which is ND1 '~ and M3 a, served as the positive control for cytolysis. SVCAS2.F6 (untransfected control) showed only background lysis. All but three clones were positive by this assay. It is possible that cell lines 16, 9, and pp14 acquired only the drug-resistance gene, rendering them G418 resistant but negative for the chimera. (b) The cell line 13 could be killed in a dose-dependent manner by graded concentrations of mCTL clone 3D5, whereas the untransfected control was not lysed. The OVA-specific mCTL clone 2G12 was included as a specificity control.
Levels of M3a-L a mRNA Were Not Limiting in Transfected Cells.
The measurement of transcript levels required probes distinguishing the chimeric mR.NA from all endogenous MHC class I transcripts. Preliminary experiments using oligonucleotides designed to react specifically with the hybrid joint of the chimeric mRNA were unsuccessful, perhaps because the juxtaposed termini of exons 3 and 4 are highly conserved. In contrast, by using regions of low homology, R.T-PCR primers could be designed that react exclusively with the M3"-L a chimera. Graded concentrations of RT product served as template in PCR reactions using oligonucleotides specific for H-2K,/~-actin, and the chimera (Fig. 3 a) . Densitometry readings of each band were then plotted against input RT template. Lines were generated from values representing ethidium bromide fluorescence of bands versus KT product used as template for PCR reaction (Fig. 3 b) . Although this assay is not a measure of absolute mRNA concentrations, these results suggest mRNA itself was not limiting surface expression of the M3~-L d chimera. Southern blot hybridization revealed that the transfectants had approximately one to five copies of the transgene (data not shown).
Very Low Cell Surface Expression of M3aIL d Chimera at
No Peptide.
Ab: 28-14-8
37~
We used the mAb 28-14-8S to determine the level of cell surface expression. As seen in Fig. 4 a, no signal was detected over the nonspecific staining of the secondary antibody alone. This pattern of nonexpression was seen in all 35 lines from two transfections, suggesting that low expression was not linked to integration of the transfected gene in a transcriptionally inactive area. The expression of endogenous K w17 molecules could be detected at wild-type levels by the antibody T~i232 at 37~ (Fig. 4 e) indicating the absence of any general defect in the transport of MHC molecules to the cell surface. Staining with anti-3zm also revealed normal levels of 32m (Fig. 4 f) . However, 13S2 cells did have some M3~-L d product on the cell surface as previously demonstrated in Fig. 2 by specific CTL reactivity. CTLs require only 50-200 peptide-class I complexes for efficient lysis (53) . In contrast, flow cytometric analysis requires at least 1,000 molecules for detection (54) . Therefore, the amount of M3~-L a on the cell surface was <1% of the number of K wt7 molecules in these transfectants. gested that the assembly pathway and its related proteins were functioning properly. We therefore evaluated the role of intracellular peptides specific for M3 a in surface expression. Data from other laboratories using the RMA-S mutant cell line have shown that incubation with peptide could stabilize empty H chains on the cell surface (55) . Additionally, cold temperature is thought to allow the egress of H chain from the endoplasmic reticulum through the Golgi apparatus and to the cell surface (56) . Either cold temperature (26~ or specific peptide restored MHC class I expression on P, MA-S cells to near wild-type levels (57) . To determine the effect of cold temperature and peptide on the expression of the chimera, we incubated 13S2 cells at 26~ or 37~ for 16 h in the presence or absence of 5/xM f-Bla-z peptide. As seen in Fig. 4 c, the chimera could be detected at the surface of cells incubated at 26~ using the anti-L d antibody. This indicated that the chimera retained the epitope for this antibody, which thus could be used to track the molecule through the cell. Peptide incubation at 26~ resulted in significantly more cell surface expression than either condition alone (Fig. 4, b-d) .
Surface Expression of M3a-L d Chimera Could Be Induced with
Additionally, the kinetics of appearance of the chimera at the cell surface using cold temperature and specific peptide were similar to the kinetics of induction of H-2K b in RMA-S cells (data not shown).
To assess the physical state of the chimeric protein, 13S2 cells and SVCAS2.F6 cells (untransfected controls) were incubated at either 37~ or 26~ in the presence or absence of 500 nM f-Bla-z peptide for 16 h. Cell surface proteins were labeled with 12si. Transfected cells treated with cold temperature and peptide showed the greatest amount of material at 50 kD, the predicted size of the glycosylated chimeric H chain (Fig. 5 a) . The H chain was also immunoprecipitated from cells that were treated with 37~ plus peptide or with cold temperature alone, but in lesser amounts. Two additional bands (23 and 28 kD) could be seen in the lanes with peptide. Immunoreactivity with 28-14-8S in immunoblots suggested that the 28-kD band was a degradation product of the H chain (Fig. 5 b) . Control immunoprecipitations with K wit under identical conditions did not yield any degradation products (data not shown).
The M3a-L a Chimera Retained the Peptide Binding Characteristics of Native M3 a. The fine specificity of native M3 a for peptide binding was established earlier by CTL-peptide competition assays. These studies established that M3 a could bind certain synthetic mitochondrial and bacterial peptides (26) . The ability to monitor peptide binding by cell surface stabilization of the H chain in the presence of specific peptide and cold temperature allowed us to determine whether M3a-L a possessed the peptide binding specificity of the native molecule by testing a panel of M3a-binding and nonbinding peptides. As seen in Fig. 6 , the N-formyl ND1%-12 mitochondrial peptide, the N-formyl ribosomal L25 peptide from E. coli, the N-formyl 3-1actamase peptide from E. coli
Similarly, the upregulation of cell surface expression by peptide and cold temperature was peptide specific; the acetylated and nonsubstituted Bla-z peptides caused no specific increase of staining over cold temperature alone (data not shown). These peptides did not affect surface expression of K wt7, a control M H C class I molecule (data not shown). Moreover, the peptides bound in an N-formyl-dependent manner, which resembled the peptide-binding profile of the native molecule. Finally, an N-formylated version of the vesicular stomatitis virus nucleoprotein (fVSVNPs2-sg), which has been shown not to bind M3 a (25), also did not stabilize the H chain above cold temperature background.
In Vitro Stabilization of the MHC-Peptide Ternary Complex by Addition of Exogenous Peptide.
The collective data suggest that peptide was the limiting component in the formation of the ternary M H C complex. In this respect, 13S2 cells resemble RMA-S cells, as well as other mutant cells (58, 59) in which the availability of peptide is limited by a defect in the putative peptide transporter protein. Whereas the defect in RMA-S cells and others affect all M H C class I proteins, low surface expression was limited to M3~-L a in these transfectants. Other investigators have shown that if specific peptide were added to RMA-S cell lysates, formation of the MHC H chain-B2m-peptide complex could be seen as determined by the appearance of peptide-dependent, conformationaUy sensitive epitopes, induding the association with 32m (60) (61) (62) . In contrast, no such dependence on peptide was seen in lysates from R M A cells, implying that endogenously bound peptides do not dissociate from H chains in this assay (60) .
We immunoprecipitated with the conformationally in-161 Vyas et al. overexposed gel (Fig. 7 a, lane 2) . In contrast, immunoprecipitation with peptide-treated lysates yielded both heavy chain and 32m. Hence, although H chain can associate with 32m quite well, it did so only in the presence of sufficient cognate peptide. 32m could be coprecipitated with the H chain in cell lysates in a manner dependent on the concentration of f-Bla-z (Fig. 7, b and c) . Finally, 32m did not associate with the H chain if lysates were treated with 200/zM Ac-Bla-z or Bla-z peptide, indicating that this ternary complex formation occurred only in the presence of specific peptide (Fig.  7, b and c) .
Discussion
In this report, we have demonstrated that cell surface expression of an M3~-L d chimera is governed by the availability of appropriate peptides. Crystal structure analysis of MHC class I-a molecules has defined pockets within the antigenbinding groove that are thought to determine the specificity ofpeptide binding (63) (64) (65) . One feature common to all crystallized MHC class I molecules is the presence of highly conserved tyrosines at 7, 59, 159, and 171 in pocket A which may establish hydrogen bonds with the positively charged peptide NH2 terminus (66) (67) (68) . In contrast, phenylalanine occupies position 171 in M3 ~ (22) and may allow both the uncharged N-formyl moiety to bind as well as prevent the binding of most charged NH2 termini. Thus, the ultrastructure of the antigen-binding domain may allow only a narrow range of peptides to bind. This level of selectivity translates into fewer peptide-containing molecules of M3 a at the cell surface.
A model for the fate of this H chain can be proposed from these data. M3a-L amP, NA was made in the transfectants at levels comparable to other endogenous MHC class I molecules and the protein was normally translated and translocated into the endoplasmic reticulum. Here, most of the H chain was retained because it presumably had not adopted the correct conformation. Williams et al. (69) have shown that calnexin (p88), a Ca2+-sensitive, endoplasmic reticulum-resident protein, can bind MHC class I H chains. Thus, it is possible that this chimera was retained by calnexin. However, some endogenous (mitochondrial) peptide was accessible to and was bound by the chimera in the endoplasmic reticulum. 32m also bound stably, forming a ternary complex that was transported to the cell surface rendering these transfectants sensitive to M3~-restricted mCTLs. However, the number of cell surface complexes was quite small as the ceils were negative by surface staining. Cold temperature may allow empty H chains to adopt the correct conformation, to release from the quality control machinery in the endoplasmic reticulum and to egress to the cell surface via the Golgi complex. Alternatively, but not mutually exclusively, reduced temperatures may inhibit proper function of the endoplasmic reticulum-resident proteins, causing empty H chains not to be retained. In any case, empty molecules are allowed to come to the cell surface. These molecules are still relatively unstable. Addition of specific peptide stabilizes the M3a-L d chimeras and increases their steady-state surface expression.
The chimeric M3a-L d molecule resembles that of MHC class I molecules in RMA-S cells. In both systems, one sees low or absent surface expression of MHC class I molecules. Both systems can be described as a peptide deprivation phenotype (70) . Whereas the defect in processing in R, MA-S cells is at the level of the peptide pump, in the M3~-L a transfectants, it is at the level of H chain specificity for peptide. For both RMA-S cells and the chimera transfectants, the incubation at 26~ greatly increases relevant class I expression at the cell surface. However, there is one major difference. Whereas peptide was sufficient to stabiIize empty molecules in RMA-S cells at 37~ it did not cause an appreciable increase in cell surface expression in the 13S2 cells. Hence, the level of empty chimeric molecules at 37~ at the cell surface is quite small in contrast to R.MA-S cells.
Low level constitutive expression is a general feature of class I-b molecules. Since peptide is the limiting factor for expression of the M3a-L d chimera, other class I molecules with low cell surface expression may be limited by endogenous peptides. In this respect, the L ~ molecule resembles a class I-b molecule. The L a molecule has been shown to have low constitutive cell-surface expression, but is induced fourfold by the addition of specific peptide (33, 50) , suggesting that L d may possess an unusual biochemical specificity for peptides. Additionally, HLA-C and HLA-E in humans are found at low levels at the cell surface (71, 72) . We suggest that for all of these molecules, extraordinary selectivity of peptide binding intracellularly may result in lower surface expression.
As with other MHC class I molecules (73, 74) , the M3 ~-L a chimera conformationally changed upon peptide binding. This was most clearly identified when peptide was added to labeled cell lysates and induced the formation of the ternary complex. Also, when 125I-labeled material was immunoprecipitated from cells incubated at either 37 or 26~ in the presence of peptide, two additional bands were detected. Western blot analysis showed that 28-14-8S reacted with one of the lower molecular weight bands, indicating that it retained the antibody epitope. The fact that this degradation product was seen only when peptide was added to cells suggests that peptide binding to the chimera may cause a conformational change in the H chain, allowing a trypsin-sensitive site to be exposed. Conformational effects on the H chain by peptide have been seen with other MHC class I molecules (75, 76) .
The conclusion that the cell surface expression of M3 ~ is strictly regulated by the availability of endogenous peptides has important implications for peptide elution from MHC molecules. Strategies employed to increase the amount of H chain by the use of strong heterologous promoters may not yield increased expression of relevant molecules on the cell surface. The data from our studies suggest that surface expression of MHC molecules is regulated posttranslationally. For most MHC class I-a molecules, the peptide pool is not limiting and thus overexpression of these molecules at the cell surface can be achieved. However, for M3 a and possibly other class I molecules that possess a narrow biochemical specificity for their peptide ligands, overexpression of the H chain may result in little change at the cell surface, making peptide elution from surface molecules more difficult.
A number of specific hypotheses can be proposed to explain the limited availability of M3a-binding peptides to the M3 a antigen-binding deft. The simplest explanation is that low rates of synthesis of N-formyl peptides limits peptide concentration at the site of loading. Alternatively, postsynthetic mechanisms may play a role in limiting peptides. These include proteolytic cleavage by proteasome, ubiquitination, and autophagy of organdies (3, 77, 78) . The proteosome machinery, including the LMP2 and LMP7 subunits, has been put forth as the leading candidate for the process of peptide generation for MHC class I molecules (3, 79) . Peptide transport by TAP might demonstrate selectively inefficient transport of N-formylated peptides. Finally, chaperones or other hypothesized loading proteins involved with MHC class I loading might limit the rate of formation of peptide-M3 a complexes. Peptide limited high expression of the M3a-L a chimera. This leads us to propose that the pool of N-formylated peptides might rise substantially after invasion by intracellular bacteria. When N-formyl peptides derived from such bacteria interact with retained H chains, the complex will egress to the cell surface, signaling CD8 + T cells of its infected state. By extension, we propose that other MHC H chains similar to M3 a and L a in displaying narrow biochemical specificities for their peptide ligands localize predominantly to the endoplasmic reticulum. Upon infection by organisms that generate appropriate antigens, these specialized MHC class I molecules will be mobilized to the cell surface. If such MHC class I molecules are poorly expressed in the thymus, this hypothesis further predicts that specialized molecules will uncommonly serve as selecting agents during thymic education, perhaps accounting for the low precursor frequency of class I-b restricted T cells in the peripheral lymphoid tissues.
